105 related articles for article (PubMed ID: 30044952)
1. Synthesis of dansyl labeled sphingosine kinase 1 inhibitor.
Park EY; Lee T; Oh YS; Lee JY; Shrestha J; Hong SW; Jin YJ; Jo G; Kim S; Hwang GT; Han DS; Baek DJ
Chem Phys Lipids; 2018 Sep; 215():29-33. PubMed ID: 30044952
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Biological Evaluation of BODIPY-PF-543.
Shrestha J; Hwang GT; Lee T; Kim SW; Oh YS; Kwon Y; Hong SW; Kim S; Seop Moon H; Baek DJ; Park EY
Molecules; 2019 Dec; 24(23):. PubMed ID: 31810327
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of PF-543 Derivative Containing Aliphatic Side Chain.
Kim SW; Lee T; Oh YS; Shin SM; Lee JY; Kim S; Baek DJ; Park EY
Chem Pharm Bull (Tokyo); 2019; 67(6):599-603. PubMed ID: 31155566
[TBL] [Abstract][Full Text] [Related]
4. Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity.
Kim SB; Lee T; Moon HS; Ki SH; Oh YS; Lee JY; Kim SB; Park JE; Kwon Y; Kim S; Baek DJ; Park EY
Molecules; 2020 May; 25(11):. PubMed ID: 32471162
[TBL] [Abstract][Full Text] [Related]
5. A Dansyl-Modified Sphingosine Kinase Inhibitor DPF-543 Enhanced De Novo Ceramide Generation.
Shamshiddinova M; Gulyamov S; Kim HJ; Jung SH; Baek DJ; Lee YM
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502095
[TBL] [Abstract][Full Text] [Related]
6. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension.
MacRitchie N; Volpert G; Al Washih M; Watson DG; Futerman AH; Kennedy S; Pyne S; Pyne NJ
Cell Signal; 2016 Aug; 28(8):946-55. PubMed ID: 27063355
[TBL] [Abstract][Full Text] [Related]
7. In Silico Identification of Novel Orthosteric Inhibitors of Sphingosine Kinase 1 (SK1).
Bayraktar O; Ozkirimli E; Ulgen KO
Curr Protein Pept Sci; 2018; 19(5):430-444. PubMed ID: 27829348
[TBL] [Abstract][Full Text] [Related]
8. Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2.
Adams DR; Tawati S; Berretta G; Rivas PL; Baiget J; Jiang Z; Alsfouk A; Mackay SP; Pyne NJ; Pyne S
J Med Chem; 2019 Apr; 62(7):3658-3676. PubMed ID: 30889352
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity.
Sibley CD; Morris EA; Kharel Y; Brown AM; Huang T; Bevan DR; Lynch KR; Santos WL
J Med Chem; 2020 Feb; 63(3):1178-1198. PubMed ID: 31895563
[TBL] [Abstract][Full Text] [Related]
10. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases.
Gao P; Peterson YK; Smith RA; Smith CD
PLoS One; 2012; 7(9):e44543. PubMed ID: 22970244
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of (S)-FTY720 vinylphosphonate analogues and evaluation of their potential as sphingosine kinase 1 inhibitors and activators.
Liu Z; MacRitchie N; Pyne S; Pyne NJ; Bittman R
Bioorg Med Chem; 2013 May; 21(9):2503-10. PubMed ID: 23541833
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of PP2A-Activating PF-543 Derivatives and Investigation of Their Inhibitory Effects on Pancreatic Cancer Cells.
Kim SB; Oh YS; Kim KJ; Cho SW; Park SK; Baek DJ; Park EY
Molecules; 2022 May; 27(10):. PubMed ID: 35630821
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine Kinase 2 in Autoimmune/Inflammatory Disease and the Development of Sphingosine Kinase 2 Inhibitors.
Pyne NJ; Adams DR; Pyne S
Trends Pharmacol Sci; 2017 Jul; 38(7):581-591. PubMed ID: 28606480
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine kinase 1 (SK1) allosteric inhibitors that target the dimerization site.
Bayraktar O; Ozkirimli E; Ulgen K
Comput Biol Chem; 2017 Aug; 69():64-76. PubMed ID: 28587987
[TBL] [Abstract][Full Text] [Related]
15. Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543.
Ju T; Gao D; Fang ZY
Biochem Biophys Res Commun; 2016 Feb; 470(3):728-734. PubMed ID: 26775841
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances.
Pyne S; Adams DR; Pyne NJ
Prog Lipid Res; 2016 Apr; 62():93-106. PubMed ID: 26970273
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase 1 protects renal tubular epithelial cells from renal fibrosis via induction of autophagy.
Du C; Ren Y; Yao F; Duan J; Zhao H; Du Y; Xiao X; Duan H; Shi Y
Int J Biochem Cell Biol; 2017 Sep; 90():17-28. PubMed ID: 28733250
[TBL] [Abstract][Full Text] [Related]
18. Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart.
Vessey DA; Kelley M; Zhang J; Li L; Tao R; Karliner JS
J Biochem Mol Toxicol; 2007; 21(5):273-9. PubMed ID: 17912702
[TBL] [Abstract][Full Text] [Related]
19. Introduction of a Polar Functional Group to the Lipid Tail of 4-epi-Jaspine B Affects Sphingosine Kinase Isoform Selectivity.
Inuki S; Miyagawa T; Oishi S; Ohno H
Chem Pharm Bull (Tokyo); 2018; 66(9):866-872. PubMed ID: 30175743
[TBL] [Abstract][Full Text] [Related]
20. Assessing the ligand selectivity of sphingosine kinases using molecular dynamics and MM-PBSA binding free energy calculations.
Fang L; Wang X; Xi M; Liu T; Yin D
Mol Biosyst; 2016 Apr; 12(4):1174-82. PubMed ID: 26927311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
